摘要
近年来,我国心肌梗死的发病率和病死率正急剧升高。对这一日益增加的人群,有效地进行二级预防显得极为迫切。目前公认作为心肌梗死二级预防的西药主要有四种:抗血小板制剂、他汀类、β-受体阻滞剂和血管紧张素转换酶抑制剂。本文主要对这四类药物应用的最新进展进行了概述,并对中医药在心肌梗死二级预防的应用前景进行了分析。
Recent years ,the morbidity and mortality of myocardial infarction are rapidly increasing. For such increasing population, secondary prevention is quite urgent.Lately, four categories of drugs have been generally accepted as secondary prevention of myocardial infarction： anti-platelet agents, Statins, Beta-blockers and Angiotensin converting enzyme inhibitors.This article mainly overviewed the latest advancement of such four categories of drugs,and discussed the applicable prospect of Traditional Chinese Medicine in secondary prevention of myocardial infarction.
出处
《医学综述》
2007年第4期263-265,共3页
Medical Recapitulate
基金
国家十五科技攻关计划项目资助(2004BA716B01)
关键词
二级预防
西药
中医药
心肌梗死
Myocardial infarction
Secondary prevention
Western medicine
Traditional Chinese medicine
